Donate

Blog

The Cold Cost of American Capitalism

The Cold Cost of American Capitalism

My life is a roller coaster ride of uncertainty. I just want the tools I need to manage my life and to experience a semblance of happiness. Instead, I am squabbling with insurance and pharmaceutical companies to provide the care that I believe is my natural human right. The injustices experienced by type 1 diabetics in this country amount to a form of massacre. Read more

Diabetes and the “American Dream”

Diabetes and the “American Dream”

I was diagnosed with type 1 diabetes when I was 12, after my mom noticed I had lost an extreme amount of weight after three days at summer camp. She had my uncle, a type 2 diabetic test my blood sugar, like he had many times before because of my fascination with medical equipment. Except this time, something was wrong. Read more

America is Number 1 - in Diabetes Costs

America is Number 1 - in Diabetes Costs

Everyone likes being #1, and Americans are no exception. Few Americans will be celebrating that they have the world’s highest out of pocket costs for insulin and other life-saving diabetes supplies. Read more

An update on Insulin for Syrians

An update on Insulin for Syrians

Many of you supported T1International’s Insulin for Syrians campaign last year, when we raised funds for our partner organisation, the Syrian American Medical Society (SAMS) to ensure that people living with diabetes amidst the crisis in Syria would be able to have access to insulin and basic supplies. Read this update about the situation now and how your donation helped. Read more

Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers

Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers

The law firm Hagens Berman has filed a complaint against Eli Lilly, Novo Nordisk, and Sanofi, the ‘big three’ pharmaceutical companies that hold a near-monopoly on the insulin market. People living with type 1 diabetes will be the plaintiffs in this class action lawsuit, which alleges that Eli Lilly, Novo Nordisk and Sanofi have unjustly inflated their prices. Read more

Supporting Refugees with type 1 diabetes in Germany

Supporting Refugees with type 1 diabetes in Germany

When refugees arrive in Germany and apply for asylum, the registration office and the doctors of Berlin’s refugee health department are the first people they meet. Oftentimes it is their first opportunity to see a health care professional in weeks or even months. During the past two years our health care system here in Germany has been overwhelmed by the large amount of immigrants coming to Europe. Many refugees got sick on their long and exhausting trip... Read more

T1International Year in Review: 2016

T1International Year in Review: 2016

What did T1International achieve in 2016? Lots! We raised funds to get insulin to Syrians in need, we carried out our Insulin & Supply survey to show how unaffordable type 1 diabetes really is, we launched the Type 1 Access Charter as well as the Advocacy toolkit, and so much more! Read more

Diabetes in Russia

Diabetes in Russia

Last February, I had the opportunity to leave my rural Cheshire home for a week to travel to Moscow. While there, I met with 3 women with diabetes. We shared stories and compared experiences, and my eyes were opened to the vastly different challenges that they face. Read more

Eli Lilly and Novo Nordisk: More Empty Promises

Eli Lilly and Novo Nordisk: More Empty Promises

Outrage at soaring insulin prices in the USA has been increasing. More patients and families are speaking out against unaffordable costs for life-saving medication than ever before. In response, two of the 'Big Three' insulin makers (who control over 90% of the insulin market) have recently made moves to combat this anger. Read more

Pharmadness: Your Chance to be a Pharma Company CEO

Pharmadness: Your Chance to be a Pharma Company CEO

Last month the Missing Medicines campaign, of which T1International is proudly a member, launched a new interactive game to illustrate the problems with the global research and development model. This experience is something that everyone should a few minutes to try. Read more